Medicine and Dentistry
Patient
100%
Chemotherapy
26%
Therapeutic Procedure
23%
Rectum Cancer
16%
Overall Survival
15%
Inpatient
15%
Peritoneum Metastasis
15%
Surgery
14%
Radiation
12%
Cytoreductive Surgery
12%
Systemic Therapy
12%
Neoplasm
11%
Hyperthermic Intraperitoneal Chemotherapy
11%
Distant Metastasis
10%
Diarrhea
10%
Platinum
10%
Head and Neck Cancer
10%
Patient-Reported Outcome
10%
Association
9%
Capecitabine
9%
Arm
9%
Venous Ulcer
9%
Liver
8%
Metastatic Carcinoma
8%
Colorectal Liver Metastasis
8%
Lung Nodule
7%
COVID-19
7%
Liver Metastasis
7%
Nephrotoxicity
7%
Survival
6%
Neoadjuvant Chemotherapy
6%
Chemoradiotherapy
6%
Radiation Therapy
5%
Acute Kidney Injury
5%
Incidence
5%
Stereotactic Body Radiation Therapy
5%
Peritoneum Cancer
5%
Progression Free Survival
5%
Pharmacology, Toxicology and Pharmaceutical Science
Toxicity
15%
Irinotecan
13%
Overall Survival
11%
Capecitabine
10%
Progression Free Survival
10%
Intraperitoneal Chemotherapy
10%
Platinum
10%
Methotrexate
10%
Duragesic
10%
Peritoneum Metastasis
9%
Chemotherapy
9%
Clinical Trial
8%
Omeprazole
7%
Neoplasm
7%
Nephrotoxicity
7%
Pharmacokinetics
6%
Acute Kidney Failure
5%
Drug
5%
Squamous Cell Carcinoma
5%
Cetuximab
5%
Mucosa Inflammation
5%
Peritoneum Cancer
5%
Xerostomia
5%